Intervention

ICS/LABA

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled AsthmaNCT06572228 · 2024-08-26

ACTIVE_NOT_RECRUITING

Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant AsthmaNCT05596721 · 2023-01-01

Effects of Leukotriene Modulator Montelukast on Cough Variant AsthmaNCT01404013 · 2012-02-01

Common conditions

Asthma3 Azithromycin1 Chest Syndrome1 Effect of Drug1

Leading sponsors

Regeneron Pharmaceuticals1 Second Affiliated Hospital, Zhejiang University, School of Medicine1 The First Affiliated Hospital of Guangzhou Medical University1

Trial status mix

UNKNOWN2

ACTIVE_NOT_RECRUITING1

Phase mix

PHASE43

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.